Electroacupuncture Relieves Visceral Hypersensitivity via Balancing PAR2 and PAR4 in the Descending Pain Modulatory System of Goats

Electroacupuncture Relieves Visceral Hypersensitivity via Balancing PAR2 and PAR4 in the Descending Pain Modulatory System of Goats

Electroacupuncture (EA) is an efficient treatment for visceral hypersensitivity (VH). However, the mechanism underlying VH remains obscure. This study aimed to examine the effect of EA at Housanli acupoint on PAR2 and PAR4 expression in the periaqueductal gray (PAG), rostral ventromedial medulla (RV...

Full description

Bibliographic Details
Main Authors:	Panpan Guo, Qiulin Zhang, Sha Nan, Haolong Wang, Ning Ma, Faisal Ayub Kiani, Mingxing Ding, Jianguo Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Brain Sciences
Subjects:	electroacupuncture (EA) TNBS visceral hypersensitivity visceromotor response protease-activated receptor 2 (PAR2) protease-activated receptor 4 (PAR4)
Online Access:	https://www.mdpi.com/2076-3425/13/6/922

Similar Items

PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
by: Shoshana Sedley, et al.
Published: (2022-08-01)

Species Differences in Platelet Protease-Activated Receptors
by: Stephanie A. Renna, et al.
Published: (2023-05-01)

First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants
by: Samira Merali, et al.
Published: (2023-12-01)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
by: Julian Friebel, et al.
Published: (2021-12-01)

Entamoeba histolytica-secreted cysteine proteases induce IL-8 production in human mast cells via a PAR2-independent mechanism
by: Lee Young Ah, et al.
Published: (2014-01-01)

GPCR Partners as Cancer Driver Genes: Association with PH-Signal Proteins in a Distinctive Signaling Network
by: Jeetendra Kumar Nag, et al.
Published: (2021-08-01)

Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries
by: Gal Reches, et al.
Published: (2022-11-01)

Proteinases as hormone-like signal messengers
by: MD Hollenberg, et al.
Published: (2005-07-01)

Cathepsin S Evokes PAR<sub>2</sub>-Dependent Pain in Oral Squamous Cell Carcinoma Patients and Preclinical Mouse Models
by: Nguyen Huu Tu, et al.
Published: (2021-09-01)

Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions
by: Rachel A. Rigg, et al.
Published: (2019-01-01)

Activation of Human Platelets by <i>Staphylococcus aureus</i> Secreted Protease Staphopain A
by: Amie K. Waller, et al.
Published: (2022-10-01)

PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model
by: Bianca N. Mason, et al.
Published: (2023-04-01)

The APC-EPCR-PAR1 axis in sickle cell disease
by: Nirupama Ramadas, et al.
Published: (2023-07-01)

Nociceptive Sensitization by Activation of Protease-Activated Receptor 2 in a Rat Model of Incisional Pain
by: Kanta Kido, et al.
Published: (2021-01-01)

Protease Activated Receptor 1 and Its Ligands as Main Regulators of the Regeneration of Peripheral Nerves
by: Elena Pompili, et al.
Published: (2021-11-01)

Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902
by: Simeng Li, et al.
Published: (2021-10-01)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
by: Xu Han, et al.
Published: (2021-01-01)

Cytotoxic CD8<sup>+</sup> T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
by: Julian Friebel, et al.
Published: (2022-12-01)

Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis
by: Michelle De bruyn, et al.
Published: (2021-10-01)

Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity
by: Rachel Price, et al.
Published: (2021-01-01)

A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF
by: Valery Golderman, et al.
Published: (2020-03-01)

Cytodifferentiation of Wulzen's cone of mature male sheep hypophysis cerebri with special emphasis on its parenchymal correlations with the adjacent Pars distalis, Pars intermedia and Pars nervosa
by: Naief Dahran, et al.
Published: (2023-06-01)

Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signalling
by: Xin Zhuo, et al.
Published: (2024-03-01)

Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma
by: Aditi Kothari, et al.
Published: (2021-05-01)

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation
by: Julian Friebel, et al.
Published: (2024-04-01)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
by: Patricia P. Wadowski, et al.
Published: (2019-07-01)

PAR2-Induced Tissue Factor Synthesis by Primary Cultures of Human Kidney Tubular Epithelial Cells Is Modified by Glucose Availability
by: Tyrone L. R. Humphries, et al.
Published: (2021-07-01)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
by: Niklas Fabio Wohlwend, et al.
Published: (2023-09-01)

Perinatal lethality of Par4–/– mice delivered by primiparous dams reveals spontaneous bleeding in mice without platelet thrombin receptor function
by: Shauna L. French, et al.
Published: (2018-02-01)

Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect
by: Francesco Grandoni, et al.
Published: (2019-01-01)

PAR4-Mediated PI3K/Akt and RhoA/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells
by: Yunkyung Heo, et al.
Published: (2022-01-01)

Combination of Models to Generate the First PAR Maps for Spain
by: Francisco Ferrera-Cobos, et al.
Published: (2021-12-01)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
by: Maurizio Benucci, et al.
Published: (2022-12-01)

Neuroprotective Effects of Noncanonical PAR1 Agonists on Cultured Neurons in Excitotoxicity
by: Irina Babkina, et al.
Published: (2024-01-01)

New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms
by: Anna Gorrasi, et al.
Published: (2020-11-01)

Critical analysis of moderate and severe retractions in the pars tensa and pars flaccida of the tympanic membrane
by: Inesângela Canali, et al.
Published: (2023-01-01)

Sensing of protease activity as a triggering mechanism of Th2 cell immunity and allergic disease
by: Audrey Meloun, et al.
Published: (2023-09-01)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
by: Mitali Das, et al.
Published: (2022-01-01)

Pars Plana Lensectomy Combined with Pars Plana Vitrectomy in Traumatic Ectopia Lentis
by: Dilek Yasa
Published: (2017-12-01)

Expression and clinical implications of PARs in the stenotic tissue of ureteropelvic junction obstruction
by: Tianyi Wang, et al.
Published: (2023-12-01)